Shelf life – Page 40

How Wrong Test Parameters Lead to Incomplete Stability Claims

Addressing Incomplete Stability Claims Due to Incorrect Test Parameters Incomplete stability claims can severely hinder product approval processes and market readiness. When stability study design errors occur, it often leads…

Stability Requirements for Site Transfers and Manufacturing Scale-Up

Essential Strategies for Addressing Regulatory Requirements During Site Transfers and Manufacturing Scale-Up In the ever-evolving landscape of pharmaceutical manufacturing, companies frequently face challenges when transferring products between sites or scaling…

How to Link Photostability Data with Packaging Material Selection

Connecting Photostability Data with Packaging Material Decisions In the pharmaceutical industry, ensuring the stability of products throughout their shelf-life is paramount. A common challenge arises during photostability studies, where discrepancies…

Stability Study Design for High-Risk APIs: Common Oversights

Identifying and Correcting Stability Study Design Errors in High-Risk APIs Stability study design errors can severely impact product quality and regulatory compliance, especially for high-risk Active Pharmaceutical Ingredients (APIs). These…

How to Justify Bracketing and Matrixing Designs to Regulators

Strategies for Justifying Bracketing and Matrixing Designs to Regulators Pharmaceutical manufacturers often face the challenge of demonstrating compliance with regulatory expectations for stability studies, especially concerning bracketing and matrixing designs.…

Photostability Failures in Injectable Products and CCI Considerations

Addressing Failures in Photostability Testing for Injectable Products and CCI Considerations Photostability study failures can significantly impact the acceptability and marketability of injectable pharmaceutical products. These failures, which can lead…

How Poor Matrix Planning Creates Unusable Stability Results

Exploring Problems with Matrix Planning in Stability Studies Stability study design errors can lead to unusable results, impacting regulatory compliance and product lifecycle management. Such issues are often traced back…

Regulatory Expectations for Photostability and Light Protection Claims

Navigating Regulatory Requirements for Photostability and Light Protection in Stability Studies The pharmaceutical sector continually grapples with the imperative to deliver safe and effective products, which necessitates a firm grasp…

How to Write CAPA for Failed Photostability Study Results

Effective Steps to Address Photostability Study Failures Photostability study failures can pose significant challenges in pharmaceutical manufacturing and quality assurance, impacting product approval and patient safety. Understanding how to respond…

Stability Study Design Errors in Zone IVb Market Submissions

Design Flaws in Stability Studies for Zone IVb Markets: Identifying and Correcting Errors Stability study design errors can present significant challenges for pharmaceutical manufacturers aiming to submit compliant products to…

How to Handle Stability Data Gaps Before Submission Filing

Addressing Gaps in Stability Data Prior to Submission Filing Pharmaceutical companies often encounter stability data gaps during product development, which can pose significant challenges just before submission filing. These gaps…

Photostability Failure Due to Incorrect Lux Hour Calculation

Addressing Photostability Study Failures Linked to Miscalculated Lux Hours Photostability study failures represent a significant concern within pharmaceutical quality assurance processes, particularly when miscalculations in lux hours adversely affect stability…